If you need more lookups,
subscriptions start at $34 USD/month.
David Brott Location
Wilmington, DE, US
David Brott Work
Head Target Organ Toxicities, OISI and Benefit Risk (Translational Patient Safety) @ (September 2019 - Present)
Director Clinical Safety - Translational and Biomarker @ AstraZeneca R&D (January 2011 - September 2019)
Principal Scientist @ (January 2003 - January 2011)
Investigator @ (January 2000 - January 2003)
David Brott Education
University of Michigan
Doctor of Philosophy (Ph.D.) (Toxicology)
2003-2006
University of Michigan
Master of Public Health (MPH) (Toxicology)
1989-1992
David Brott Skills
Biomarkers
Hematopoiesis
Toxicology
in vivo
in vitro
Assay Development
Drug Discovery
Clinical Research
Translational Medicine
Validation
Biotechnology
Cross-cultural Communication Skills
Drug Development
Cross Functional Team Building
Microbiology
Cross Cultural Communication Skills
David Brott Summary
David Brott, based in Wilmington, DE, US, is currently a Head Target Organ Toxicities, OISI and Benefit Risk (Translational Patient Safety) at Takeda. David Brott brings experience from previous roles at AstraZeneca R&D, AstraZeneca Pharmaceuticals - Global Safety Assessment and GlaxoSmithKline. David Brott holds a 2003 - 2006 Doctor of Philosophy (Ph.D.) in Toxicology @ University of Michigan. With a robust skill set that includes Biomarkers, Hematopoiesis, Toxicology, in vivo, in vitro and more. David Brott has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different David Brott?
Find contact details for 700 million professionals.